Inhibition of cell proliferation in human breast tumor cells by antisense oligonucleotides against facilitative glucose transporter 5
- 24 September 2004
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 93 (6) , 1134-1142
Abstract
In recent years, successful examples of antisense oligonucleotide (AS) therapy for genetic diseases have stimulated scientists to investigate its application on cancer diseases. AS can be used to down‐regulate the mRNA and protein expression by annealing to specific region of the target mRNA which is responsible for the malignancy. Glucose transporter 5 (Glut5) is a tissue specific transporter that can be found on breast cancer tissues but not on normal breast tissues. Therefore, it is of clinical interest to investigate whether AS against Glut5 mRNA can tackle breast cancer. In this study, two cell lines, MCF‐7 which is estrogen‐receptor positive and MDA‐MB‐231 which is estrogen‐receptor negative, were used to mimic breast cancer tissues at early and late stages, respectively. A 15‐base sequence around the start codon of Glut5 was used. It was found that AS against Glut5 exerted anti‐proliferative effect on both of these two breast tumor cell lines and seemed to exert its effect via the suppression of expression of Glut5 proteins in the cells. AS against Glut5 exhibited no effect on human hepatoma HepG2 cells which do not possess any Glut5. The results imply an alternative way in treating breast tumor as the AS against Glut5, unlike tamoxifen, takes effect on breast tumor cells via suppressing the expression of Glut5 that they specifically possess, and regardless whether the breast tumors are estrogen dependent or not.Keywords
This publication has 18 references indexed in Scilit:
- Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteinsBritish Journal of Nutrition, 2003
- Synthesis of Antisense Oligonucleotide−Peptide Conjugate Targeting to GLUT-1 in HepG-2 and MCF-7 CellsBioconjugate Chemistry, 2002
- Differential Expression of Facilitative Glucose Transporter (GLUT) Genes in Primary Lung Cancers and Their Liver MetastasesJapanese Journal of Cancer Research, 1999
- Synthesis and characterization of a specific peptide nucleic acid that inhibits expression of inducible NO synthaseFEBS Letters, 1998
- Antisense therapeuticsCurrent Opinion in Chemical Biology, 1998
- Expression of the fructose transporter GLUT5 in human breast cancer.Proceedings of the National Academy of Sciences, 1996
- Characterization of the rabbit intestinal fructose transporter (GLUT5)Biochemical Journal, 1994
- Differential regulation of glucose transporter isoforms by the src oncogene in chicken embryo fibroblasts.Molecular and Cellular Biology, 1991
- Over-expression of facilitative glucose transporter genes in human cancerBiochemical and Biophysical Research Communications, 1990
- Glucose regulates its own transport in Ehrlich ascites tumour cellsBiochemical and Biophysical Research Communications, 1986